This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement, National Institute of Health and Medical Research. Active years: 2012-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 29 
3 out of 49 
3 out of 1,853 
Years Active: 2012-2024
Title: Eric Oswald: Innovator in Gastrointestinal and Pain Disorder Treatments
Introduction
Eric Oswald is a notable inventor based in Toulouse, France. He has made significant contributions to the fields of gastrointestinal health and pain management through his innovative research and inventions. With a total of 4 patents, Oswald's work focuses on utilizing modified strains of bacteria to develop new therapeutic options.
Latest Patents
One of Oswald's latest patents is centered around a modified strain of Nissle 1917 (EcN) for the treatment of gastrointestinal disorders. This invention explores the mechanisms behind the probiotic properties of EcN, demonstrating how the ClbP protein can be modified to retain its beneficial effects while eliminating its genotoxic activity. This groundbreaking research paves the way for the safe use of EcN in treating gastrointestinal diseases.
Another significant patent involves the discovery of lipopeptide compounds with analgesic properties. These compounds, derived from the probiotic strain Nissle 1917, show promise in treating pain disorders, particularly visceral pain. The research highlights how these compounds can inhibit hypersensitivity and cross cellular barriers, offering new avenues for pain management.
Career Highlights
Throughout his career, Eric Oswald has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Toulouse University Hospital (Centre Hospitalier Universitaire De Toulouse). His work in these organizations has contributed to advancements in medical research and therapeutic development.
Collaborations
Oswald has collaborated with notable colleagues, including Patricia Martin and Nicolas Cenac. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.
Conclusion
Eric Oswald's contributions to the fields of gastrointestinal health and pain management through his innovative patents demonstrate his commitment to advancing medical science. His research not only opens new therapeutic possibilities but also highlights the importance of collaboration in the innovation process.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile